The ether lipid precursor hexadecylglycerol protects against Shiga toxins

Cellular and Molecular Life Sciences

Volumn 71, Issue 21, 2014, Pages 4285-4300

  Bergan, Jonas ^a,b,c   Skotland, Tore ^a,b   Lingelem, Anne Berit Dyve ^a,b   Simm, Roger ^a,b   Spilsberg, Bjørn ^d   Lindbäck, Toril ^e   Sylvänne, Tuulia ^f   Simolin, Helena ^f   Ekroos, Kim ^f   Sandvig, Kirsten ^a,b,c  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d NORWEGIAN VETERINARY INSTITUTE   (Norway)

^e NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^f Zora Biosciences   (Finland)

Author keywords

Alkylglycerol; Endocytosis; Ether lipids; Globotriaosylceramide; Intracellular transport; Shiga toxin

Indexed keywords

CERAMIDE TRIHEXOSIDE; CHIMYL ALCOHOL; ETHER; GLOBOTRIAOSYLCERAMIDE; GLYCEROL; GLYCEROL ETHER; GLYCOSPHINGOLIPID; LIPID; PALMITIC ACID; SHIGA TOXIN;

BIOTINYLATION; CELL LINE; CELL MEMBRANE; CHEMISTRY; CYTOSOL; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; ESCHERICHIA COLI; GOLGI COMPLEX; HEK293 CELL LINE; HUMAN; IC50; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; BIOTINYLATION; CELL LINE; CELL MEMBRANE; CYTOSOL; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; ESCHERICHIA COLI; ETHER; GLYCEROL; GLYCERYL ETHERS; GLYCOSPHINGOLIPIDS; GOLGI APPARATUS; HEK293 CELLS; HUMANS; INHIBITORY CONCENTRATION 50; LIPIDS; PALMITIC ACID; SHIGA TOXIN; SHIGA TOXINS; TRIHEXOSYLCERAMIDES;

EID: 84922013685     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-014-1624-1     Document Type: Article

References (74)

1. Bergan J, Dyve Lingelem AB, Simm R, Skotland T, Sandvig K (2012) Shiga toxins. Toxicon 60:1085-1107. doi: 10.1016/j.toxicon.2012.07.016
2. Melton-Celsa A, Mohawk K, Teel L, O'Brien A (2012) Pathogenesis of Shiga-toxin producing Escherichia coli. Curr Top Microbiol Immunol 357:67-103. doi: 10.1007/82-2011-176
3. Lingwood CA, Binnington B, Manis A, Branch DR (2010) Globotriaosyl ceramide receptor function - where membrane structure and pathology intersect. FEBS Lett 584:1879-1886. doi: 10.1016/j.febslet.2009.11.089
4. Engedal N, Skotland T, Torgersen ML, Sandvig K (2011) Shiga toxin and its use in targeted cancer therapy and imaging. Microb Biotechnol 4:32-46. doi: 10.1111/j.1751-7915.2010.00180.x
5. Nathanson S, Kwon T, Elmaleh M, Charbit M, Launay EA et al (2010) Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 5:1218-1228. doi: 10.2215/CJN.08921209
6. Sandvig K, Bergan J, Dyve A-B, Skotland T, Torgersen ML (2010) Endocytosis and retrograde transport of Shiga toxin. Toxicon 56:1181-1185. doi: 10.1016/j.toxicon.2009.11.021
7. Sandvig K, Garred O, Prydz K, Kozlov JV, Hansen SH et al (1992) Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature 358:510-512. doi: 10.1038/358510a0
8. Spooner RA, Lord JM (2012) How ricin and Shiga toxin reach the cytosol of target cells: retrotranslocation from the endoplasmic reticulum. Curr Top Microbiol Immunol 357:19-40. doi: 10.1007/82-2011-154
9. Tumer NE, Li X-P (2012) Interaction of ricin and Shiga toxins with ribosomes. Curr Top Microbiol Immunol 357:1-18. doi: 10.1007/82-2011-174
10. Tesh VL (2010) Induction of apoptosis by Shiga toxins. Future Microbiol 5:431-453. doi: 10.2217/fmb.10.4
11. Arab S, Lingwood CA (1996) Influence of phospholipid chain length on verotoxin/globotriaosyl ceramide binding in model membranes: comparison of a supported bilayer film and liposomes. Glycoconj J 13:159-166. doi: 10.1007/BF00731490
12. Lingwood D, Binnington B, Róg T, Vattulainen I, Grzybek M et al (2011) Cholesterol modulates glycolipid conformation and receptor activity. Nat Chem Biol 7:260-262. doi: 10.1038/nchembio.551
13. Mahfoud R, Manis A, Binnington B, Ackerley C, Lingwood CA (2010) A major fraction of glycosphingolipids in model and cellular cholesterol-containing membranes is undetectable by their binding proteins. J Biol Chem 285:36049-36059. doi: 10.1074/jbc.M110.110189
14. Yahi N, Aulas A, Fantini J (2010) How cholesterol constrains glycolipid conformation for optimal recognition of Alzheimer's beta amyloid peptide (Abeta1-40). Plos One 5:e9079. doi: 10.1371/journal.pone.0009079
15. Katagiri YU, Mori T, Nakajima H, Katagiri C, Taguchi T et al (1999) Activation of Src family kinase yes induced by Shiga toxin binding to globotriaosyl ceramide (Gb3/CD77) in low density, detergent-insoluble microdomains. J Biol Chem 274:35278-35282. doi: 10.1074/jbc.274.49.35278
16. Mori T, Kiyokawa N, Katagiri YU, Taguchi T, Suzuki T et al (2000) Globotriaosyl ceramide (CD77/Gb3) in the glycolipid-enriched membrane domain participates in B-cell receptor-mediated apoptosis by regulating lyn kinase activity in human B cells. Exp Hematol 28:1260-1268. doi: 10.1016/S0301-472X(00)00538-5
17. Takenouchi H, Kiyokawa N, Taguchi T, Matsui J, Katagiri YU et al (2004) Shiga toxin binding to globotriaosyl ceramide induces intracellular signals that mediate cytoskeleton remodeling in human renal carcinoma-derived cells. J Cell Sci 117:3911-3922. doi: 10.1242/jcs.01246
18. Falguières T, Mallard F, Baron C, Hanau D, Lingwood C et al (2001) Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. Mol Biol Cell 12:2453-2468
19. Hoey DEE, Sharp L, Currie C, Lingwood CA, Gally DL et al (2003) Verotoxin 1 binding to intestinal crypt epithelial cells results in localization to lysosomes and abrogation of toxicity. Cell Microbiol 5:85-97. doi: 10.1046/j.1462-5822.2003.00254.x
20. Tam P, Mahfoud R, Nutikka A, Khine AA, Binnington B et al (2008) Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide-containing lipid assemblies. J Cell Physiol 216:750-763. doi: 10.1002/jcp.21456
21. Khan F, Proulx F, Lingwood CA (2009) Detergent-resistant globotriaosyl ceramide may define verotoxin/glomeruli-restricted hemolytic uremic syndrome pathology. Kidney Int 75:1209-1216. doi: 10.1038/ki.2009.7
22. Van Meer G, de Kroon AIPM (2011) Lipid map of the mammalian cell. J Cell Sci 124:5-8. doi: 10.1242/jcs.071233
23. Braverman NE, Moser AB (2012) Functions of plasmalogen lipids in health and disease. Biochim Biophys Acta 1822:1442-1452. doi: 10.1016/j.bbadis.2012.05.008
24. Nagan N, Zoeller RA (2001) Plasmalogens: biosynthesis and functions. Prog Lipid Res 40:199-229. doi: 10.1016/S0163-7827(01)00003-0
25. Gorgas K, Teigler A, Komljenovic D, Just WW (2006) The ether lipid-deficient mouse: tracking down plasmalogen functions. Biochim Biophys Acta 1763:1511-1526. doi: 10.1016/j.bbamcr.2006.08.038
26. Iannitti T, Palmieri B (2010) An update on the therapeutic role of alkylglycerols. Mar Drugs 8:2267-2300. doi: 10.3390/md8082267
27. Chae K, Piantadosi C, Snyder F (1973) An alternate enzymic route for the synthesis of the alkyl analog of phosphatidic acid involving alkylglycerol. Biochem Biophys Res Commun 51:119-124. doi: 10.1016/0006-291X(73)90516-0
28. Watschinger K, Werner ER (2013) Orphan enzymes in ether lipid metabolism. Biochimie 95:59-65. doi: 10.1016/j.biochi.2012.06.027
29. Das AK, Holmes RD, Wilson GN, Hajra AK (1992) Dietary ether lipid incorporation into tissue plasmalogens of humans and rodents. Lipids 27:401-405. doi: 10.1007/BF02536379
30. Schrakamp G, Schalkwijk CG, Schutgens RB, Wanders RJ, Tager JM et al (1988) Plasmalogen biosynthesis in peroxisomal disorders: fatty alcohol versus alkylglycerol precursors. J Lipid Res 29:325-334
31. Styger R, Wiesmann UN, Honegger UE (2002) Plasmalogen content and beta-adrenoceptor signalling in fibroblasts from patients with Zellweger syndrome. Effects of hexadecylglycerol. Biochim Biophys Acta 1585:39-43. doi: 10.1016/S1388-1981(02)00320-7
32. Brites P, Ferreira AS, da Silva TF, Sousa VF, Malheiro AR et al (2011) Alkyl-glycerol rescues plasmalogen levels and pathology of ether-phospholipid deficient mice. Plos One 6:e28539. doi: 10.1371/journal.pone.0028539
33. Raa H, Grimmer S, Schwudke D, Bergan J, Wälchli S et al (2009) Glycosphingolipid requirements for endosome-to-Golgi transport of Shiga toxin. Traffic 10:868-882. doi: 10.1111/j.1600-0854.2009.00919.x
34. Bergan J, Skotland T, Sylvänne T, Simolin H, Ekroos K et al (2013) The ether lipid precursor hexadecylglycerol causes major changes in the lipidome of HEp-2 cells. Plos One 8:e75904. doi: 10.1371/journal.pone.0075904
35. Wen SX, Teel LD, Judge NA, O'Brien AD (2006) Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge. Vaccine 24:1142-1148. doi: 10.1016/j.vaccine.2005.08.094
36. Kvalvaag AS, Pust S, Sundet KI, Engedal N, Simm R et al (2013) The ERM proteins ezrin and moesin regulate retrograde Shiga toxin transport. Traffic 14:839-852. doi: 10.1111/tra.12077
37. L'Abée-Lund TM, Jørgensen HJ, O'Sullivan K, Bohlin J, Ligård G et al (2012) The highly virulent 2006 Norwegian EHEC O103:H25 outbreak strain is related to the 2011 German O104:H4 outbreak strain. Plos One 7:e31413. doi: 10.1371/journal.pone.0031413
38. Olsnes S, Haylett T, Sandvig K (1982) The toxic lectin modeccin. Methods Enzymol 83:357-362. doi: 10.1016/0076-6879(82)83030-9
39. Dyve AB, Bergan J, Utskarpen A, Sandvig K (2009) Sorting nexin 8 regulates endosome-to-Golgi transport. Biochem Biophys Res Commun 390:109-114. doi: 10.1016/j.bbrc.2009.09.076
40. Torgersen ML, Wälchli S, Grimmer S, Skånland SS, Sandvig K (2007) Protein kinase Cdelta is activated by Shiga toxin and regulates its transport. J Biol Chem 282:16317-16328. doi: 10.1074/jbc.M610886200
41. Dyve Lingelem AB, Bergan J, Sandvig K (2012) Inhibitors of intravesicular acidification protect against Shiga toxin in a pH-independent manner. Traffic 13:443-454. doi: 10.1111/j.1600-0854.2011.01319.x
42. Grimmer S, Spilsberg B, Hanada K, Sandvig K (2006) Depletion of sphingolipids facilitates endosome to Golgi transport of ricin. Traffic 7:1243-1253. doi: 10.1111/j.1600-0854.2006.00456.x
43. Lingwood D, Simons K (2007) Detergent resistance as a tool in membrane research. Nat Protoc 2:2159-2165. doi: 10.1038/nprot.2007.294
44. Ekroos K, Chernushevich IV, Simons K, Shevchenko A (2002) Quantitative profiling of phospholipids by multiple precursor ion scanning on a hybrid quadrupole time-of-flight mass spectrometer. Anal Chem 74:941-949. doi: 10.1021/ac015655c
45. Ejsing CS, Duchoslav E, Sampaio J, Simons K, Bonner R et al (2006) Automated identification and quantification of glycerophospholipid molecular species by multiple precursor ion scanning. Anal Chem 78:6202-6214. doi: 10.1021/ac060545x
46. Jung HR, Sylvänne T, Koistinen KM, Tarasov K, Kauhanen D et al (2011) High throughput quantitative molecular lipidomics. Biochim Biophys Acta 1811:925-934. doi: 10.1016/j.bbalip.2011.06.025
47. Merrill AH Jr, Sullards MC, Allegood JC, Kelly S, Wang E (2005) Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. Methods 36:207-224. doi: 10.1016/j.ymeth.2005.01.009
48. Boerlin P, McEwen SA, Boerlin-Petzold F, Wilson JB, Johnson RP et al (1999) Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol 37:497-503
49. Honke K (2013) Biosynthesis and biological function of sulfoglycolipids. Proc Jpn Acad Ser B Phys Biol Sci 89:129-138
50. Bigay J, Antonny B (2012) Curvature, lipid packing, and electrostatics of membrane organelles: defining cellular territories in determining specificity. Dev Cell 23:886-895. doi: 10.1016/j.devcel.2012.10.009
51. Honsho M, Yagita Y, Kinoshita N, Fujiki Y (2008) Isolation and characterization of mutant animal cell line defective in alkyl-dihydroxyacetonephosphate synthase: localization and transport of plasmalogens to post-Golgi compartments. Biochim Biophys Acta 1783:1857-1865. doi: 10.1016/j.bbamcr.2008.05.018
52. Pike LJ, Han X, Chung K-N, Gross RW (2002) Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. Biochemistry 41:2075-2088. doi: 10.1021/bi0156557
53. Munn NJ, Arnio E, Liu D, Zoeller RA, Liscum L (2003) Deficiency in ethanolamine plasmalogen leads to altered cholesterol transport. J Lipid Res 44:182-192. doi: 10.1194/jlr.M200363-JLR200
54. Kanzawa N, Maeda Y, Ogiso H, Murakami Y, Taguchi R et al (2009) Peroxisome dependency of alkyl-containing GPI-anchor biosynthesis in the endoplasmic reticulum. Proc Natl Acad Sci USA 106:17711-17716. doi: 10.1073/pnas.0904762106
55. Mayinger P (2012) Phosphoinositides and vesicular membrane traffic. Biochim Biophys Acta 1821:1104-1113. doi: 10.1016/j.bbalip.2012.01.002
56. Falguières T, Römer W, Amessou M, Afonso C, Wolf C et al (2006) Functionally different pools of Shiga toxin receptor, globotriaosyl ceramide, in HeLa cells. FEBS J 273:5205-5218. doi: 10.1111/j.1742-4658.2006.05516.x
57. Arab S, Lingwood CA (1998) Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to verotoxin via globotriaosyl ceramide fatty acid isoform traffic. J Cell Physiol 177:646-660. doi: 10.1002/(SICI)1097-4652(199812)177:4<646:AID-JCP15>3.0.CO;2-B
58. Sandvig K, Ryd M, Garred O, Schweda E, Holm PK et al (1994) Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP. J Cell Biol 126:53-64. doi: 10.1083/jcb.126.1.53
59. Nishikawa K, Watanabe M, Kita E, Igai K, Omata K et al (2006) A multivalent peptide library approach identifies a novel Shiga toxin inhibitor that induces aberrant cellular transport of the toxin. FASEB J 20:2597-2599. doi: 10.1096/fj.06-6572fje
60. Kavaliauskiene S, Nymark C-M, Bergan J, Simm R, Sylvänne T et al (2014) Cell density-induced changes in lipid composition and intracellular trafficking. Cell Mol Life Sci 71:1097-1116. doi: 10.1007/s00018-013-1441-y
61. Gutiérrez-Martínez E, Fernández-Ulibarri I, Lázaro-Diéguez F, Johannes L, Pyne S et al (2013) Lipid phosphate phosphatase 3 participates in transport carrier formation and protein trafficking in the early secretory pathway. J Cell Sci 126:2641-2655. doi: 10.1242/jcs.117705
62. Smith DC, Sillence DJ, Falguières T, Jarvis RM, Johannes L et al (2006) The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect. Mol Biol Cell 17:1375-1387. doi: 10.1091/mbc.E05-11-1035
63. Utskarpen A, Slagsvold HH, Dyve AB, Skånland SS, Sandvig K (2007) SNX1 and SNX2 mediate retrograde transport of Shiga toxin. Biochem Biophys Res Commun 358:566-570. doi: 10.1016/j.bbrc.2007.04.159
64. Bujny MV, Popoff V, Johannes L, Cullen PJ (2007) The retromer component sorting nexin-1 is required for efficient retrograde transport of Shiga toxin from early endosome to the trans Golgi network. J Cell Sci 120:2010-2021. doi: 10.1242/jcs.003111
65. Van der Poel S, Wolthoorn J, van den Heuvel D, Egmond M, Groux-Degroote S et al (2011) Hyperacidification of trans-Golgi network and endo/lysosomes in melanocytes by glucosylceramide-dependent V-ATPase activity. Traffic 12:1634-1647. doi: 10.1111/j.1600-0854.2011.01263.x
66. D'Angelo G, Polishchuk E, Di Tullio G, Santoro M, Di Campli A et al (2007) Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide. Nature 449:62-67. doi: 10.1038/nature06097
67. Sprong H, Degroote S, Claessens T, van Drunen J, Oorschot V et al (2001) Glycosphingolipids are required for sorting melanosomal proteins in the Golgi complex. J Cell Biol 155:369-380. doi: 10.1083/jcb.200106104
68. Sandvig K, Skotland T, van Deurs B, Klokk TI (2013) Retrograde transport of protein toxins through the Golgi apparatus. Histochem Cell Biol 140:317-326. doi: 10.1007/s00418-013-1111-z
69. Sandvig K, Bergan J, Kavaliauskiene S, Skotland T (2014) Lipid requirements for entry of protein toxins into cells. Prog Lipid Res 54C:1-13. doi: 10.1016/j.plipres.2014.01.001
70. Lewkowicz P, Banasik M, Głowacka E, Lewkowicz N, Tchórzewski H (2005) Effect of high doses of shark liver oil supplementation on T cell polarization and peripheral blood polymorphonuclear cell function. Pol Merkur Lekarski 18:686-692
71. Bitzan M (2009) Treatment options for HUS secondary to Escherichia coli O157:H7. Kidney Int 75:S62-S66. doi: 10.1038/ki.2008.624
72. Nishikawa K (2011) Recent progress of Shiga toxin neutralizer for treatment of infections by Shiga toxin-producing Escherichia coli. Arch Immunol Ther Exp (Warsz) 59:239-247. doi: 10.1007/s00005-011-0130-5
73. Stechmann B, Bai S-K, Gobbo E, Lopez R, Merer G et al (2010) Inhibition of retrograde transport protects mice from lethal ricin challenge. Cell 141:231-242. doi: 10.1016/j.cell.2010.01.043
74. Mukhopadhyay S, Linstedt AD (2012) Manganese blocks intracellular trafficking of Shiga toxin and protects against Shiga toxicosis. Science 335:332-335. doi: 10.1126/science.1215930